Skip to main content

Aimmune Therapeu Shares Down -0.5% Since SmarTrend's Sell Call (AIMT)

SmarTrend identified a Downtrend for Aimmune Therapeu (NASDAQ:AIMT) on March 20th, 2019 at $21.45. In approximately 5 months, Aimmune Therapeu has returned 0.51% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.